Details for: PMS-CIPROFLOXACIN XL
Company: PHARMASCIENCE INC
| DIN | DIN name | Active Ingredient(s) | Strength | Dosage Form | Route of Administration |
|---|---|---|---|---|---|
| 02416433 | PMS-CIPROFLOXACIN XL | CIPROFLOXACIN (CIPROFLOXACIN, CIPROFLOXACIN HYDROCHLORIDE) | 500 MG | TABLET (IMMEDIATE AND EXTENDED RELEASE) | ORAL |
Summary Reports
Summary Safety Review - Fluoroquinolones - Assessing the potential risk of persistent and disabling side effects
Summary Safety Review - Oral FLUOROQUINOLONES - Assessing the Potential Risk of Retinal Detachment
Summary Safety Review - Fluoroquinolones - Assessing the potential risk of aneurysm (a balloon-like bulge) and dissection (a separation or tear in the layers of the wall) of the aorta (a major blood vessel)
Résumé de l'examen de l'innocuité - Fluoroquinolones inhalées et systémiques - Évaluation du risque potentiel de la régurgitation valvulaire
Summary Safety Review - Oral FLUOROQUINOLONES - Assessing the Potential Risk of Retinal Detachment
Summary Safety Review - Fluoroquinolones - Assessing the potential risk of aneurysm (a balloon-like bulge) and dissection (a separation or tear in the layers of the wall) of the aorta (a major blood vessel)
Résumé de l'examen de l'innocuité - Fluoroquinolones inhalées et systémiques - Évaluation du risque potentiel de la régurgitation valvulaire
Consumer Information
The Consumer Information is not yet available in the Drug and Health Product Register. Try searching on the active ingredient(s) to find other similar products.